Tandem Diabetes Care Inc Cash Flow Reinvestment Rate
Tandem Diabetes Care Inc cash flow reinvestment rate. Tandem Diabetes Care Inc (TNDM) has a Cash Flow Reinvestment Rate of 17.68x as of March 2026, reinvesting $195.45 Million (capex $6.27 Million plus investments $-189.18 Million) from operating cash flow of $11.05 Million. Explore Tandem Diabetes Care Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Tandem Diabetes Care Inc (2019–2024)
Cash flow reinvestment rate of Tandem Diabetes Care Inc from 2019 to 2024. Historical reinvestment intensity for Tandem Diabetes Care Inc across 5 annual periods. Explore TNDM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Tandem Diabetes Care Inc Cash Flow Reinvestment Rate by Year (2019–2024)
Tandem Diabetes Care Inc cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Tandem Diabetes Care Inc. For the full cash flow conversion analysis, see how efficiently does Tandem Diabetes Care Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.76x | $42.71 Million | $24.23 Million | $19.23 Million | ▲ +32.3% |
| 2022 | 1.33x | $67.27 Million | $50.46 Million | $34.10 Million | ▼ -20.6% |
| 2021 | 1.68x | $186.88 Million | $111.36 Million | $23.51 Million | ▼ -86.0% |
| 2020 | 12.00x | $296.06 Million | $24.67 Million | $32.29 Million | ▲ +783.0% |
| 2019 | 1.36x | $56.95 Million | $41.91 Million | $19.54 Million | — |